Positively influence pending legislative, regulatory and policy change
- Delivered full mitigation of the potential adverse fee impacts of 12-month prescriptions from 1 February 2026 – avoiding a mid-point forecast loss of $28 million per annum for the sector.
- Secured HNZ’s commitment to develop a robust nationwide contracting policy for how community pharmacies gain access to a contract.
Address pressing sector advocacy issues
- Obtained a strengthened commitment from HNZ’s Chief Executive to develop a sustainable community pharmacy funding model by July 2026 to maintain New Zealanders’ access to community pharmacy services.
- Began the much-needed work, via the Community Pharmacy Leaders Forum, to develop a comprehensive workforce plan to address workforce sustainability pressures facing community pharmacy, which we highlighted in HNZ’s 2024 Workforce Plan.
Continuously improve our core business-as-usual activity
- Significant progress in ensuring stronger and deeper community pharmacy representation at all levels throughout the health system, with effective engagement with members, key stakeholders, official advisors and government decision-makers.
- Work via the Community Pharmacy Leaders Forum towards the development of a roadmap to enable community pharmacy’s full scope of practice to achieve improved access, better health outcomes and increased value for money.
Ensure the Guild remains fit for purpose and relevant to our membership
- Developed and implemented a new membership and engagement strategy, and in the process significantly raised the profile and awareness of the Guild’s value proposition with members and non-members.
- Refreshed and reregistered the Guild’s Constitution, based on a contemporary best practice governance model with a fully appointed Board to be in place by 2027.